Jules Hirsch, MD
This content is PDF only. Please click on the PDF icon to access.
To the editors: Dr. Bray's editorial (1) elucidates some of the important barriers to treating obesity. As stated, "the public perception that obesity is a disease resulting from a lack of will power" is a major barrier to the treatment of a disease with fundamental genetic, molecular determinants. "Limited research funding" is surely another barrier. However, I am concerned about Dr. Bray's wish to lower barriers to the use of appetite-suppressant drugs.
I do not find "clear and convincing evidence that modern appetite-suppressant drugs are effective and safe." Fenfluramine, one of the drugs cited, has been shown to have potentially
Hirsch J. Barriers to Treating Obesity. Ann Intern Med. 1991;115:656–657. doi: https://doi.org/10.7326/0003-4819-115-8-656_2
Download citation file:
Published: Ann Intern Med. 1991;115(8):656-657.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use